Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

John F. Paolini

Chief Medical Officer at Kiniksa Pharmaceuticals International, plc (KNSA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8.0M

Reported trades

Filed Stock Type Shares Price Value Since
May 5SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 37,32786,720 held (−30%) $53.52 $2.0M +49.1%
May 5SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 21,09765,623 held (−24%) $54.04 $1.1M +47.6%
Mar 4SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 12,06389,261 held (−12%) $44.20 $533K +80.5%
Mar 4SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 22,22367,038 held (−25%) $44.88 $997K +77.8%
Mar 4SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 5,71461,324 held (−9%) $45.92 $262K +73.7%
Nov 4SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 82,54261,324 held (−57%) $37.14 $3.1M +114.8%
  • Sell

    Chief Medical Officer John F. Paolini sold $2.0M of KNSA at $53.52 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer John F. Paolini sold $1.1M of KNSA at $54.04 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer John F. Paolini sold $533K of KNSA at $44.20 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer John F. Paolini sold $997K of KNSA at $44.88 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer John F. Paolini sold $262K of KNSA at $45.92 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer John F. Paolini sold $3.1M of KNSA at $37.14 — cuts the stake by 57%; pre-scheduled 10b5-1 plan sale.